{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:01:45Z","timestamp":1781607705671,"version":"3.54.5"},"reference-count":32,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.3892\/ol.2014.1963","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T05:10:40Z","timestamp":1394514640000},"page":"1401-1408","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of phosphoinositide 3-kinase\/Akt pathway decreases hypoxia inducible factor-1\u03b1 expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cells"],"prefix":"10.3892","volume":"7","author":[{"given":"JING","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUA","family":"GUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIN-SHUI","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YU-CHEN","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI-XIONG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NI-WEI","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"key20180108101913_b1-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180108101913_b2-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1158\/1078-0432.CCR-06-1339","article-title":"Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background","volume":"12","author":"Tajima","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180108101913_b3-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1756-9966-28-65","article-title":"Expression of phospho-ERK1\/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations","volume":"28","author":"Li","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180108101913_b4-ol-07-05-1401","first-page":"389","article-title":"PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma","volume":"14","author":"Uegaki","year":"2005","journal-title":"Oncol Rep"},{"key":"key20180108101913_b5-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s10495-010-0497-5","article-title":"Activation of PI3K\/Akt\/IKK-alpha\/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin","volume":"15","author":"Sun","year":"2010","journal-title":"Apoptosis"},{"key":"key20180108101913_b6-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2004.07.193","article-title":"The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas","volume":"22","author":"Chakravarti","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180108101913_b7-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0270","article-title":"Akt\/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K\/Akt and TGF-\u03b2 signaling axes","volume":"2","author":"Xue","year":"2012","journal-title":"Cancer Discov"},{"key":"key20180108101913_b8-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1479-5876-9-200","article-title":"The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas","volume":"9","author":"Valkov","year":"2011","journal-title":"J Transl Med"},{"key":"key20180108101913_b9-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/JTO.0b013e3182417830","article-title":"Hypoxia-inducible factor-1\u03b1 and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study","volume":"7","author":"Lee","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key20180108101913_b10-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.lungcan.2010.08.005","article-title":"Prognostic implications of hypoxia-inducible factor-1\u03b1 in epidermal growth factor receptor-negative non-small cell lung cancer","volume":"72","author":"Park","year":"2011","journal-title":"Lung Cancer"},{"key":"key20180108101913_b11-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00277-010-1070-6","article-title":"Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1\u2192HIF-1\u03b1 pathway","volume":"90","author":"Argyriou","year":"2011","journal-title":"Ann Hematol"},{"key":"key20180108101913_b12-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"31277","DOI":"10.1074\/jbc.M300763200","article-title":"Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase\/Akt\/glycogen synthase kinase 3beta pathway in HepG2 cells","volume":"278","author":"Mottet","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180108101913_b13-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"33185","DOI":"10.1074\/jbc.M109.054221","article-title":"Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt\/protein kinase C\/histone deacetylase pathway","volume":"284","author":"Koshikawa","year":"2009","journal-title":"J Biol Chem"},{"key":"key20180108101913_b14-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/cgt.2009.66","article-title":"Silencing of HIF-1alpha suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis","volume":"17","author":"Xu","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"key20180108101913_b15-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"11263","DOI":"10.1158\/0008-5472.CAN-06-1699","article-title":"Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis","volume":"66","author":"Tanaka","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108101913_b16-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.cellsig.2007.07.025","article-title":"PI3K\/PTEN\/AKT signaling regulates prostate tumor angiogenesis","volume":"19","author":"Fang","year":"2007","journal-title":"Cell Signal"},{"key":"key20180108101913_b17-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s13277-010-0131-8","article-title":"Prognostic and predictive values of pERK1\/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy","volume":"32","author":"Shi","year":"2011","journal-title":"Tumour Biol"},{"key":"key20180108101913_b18-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.advenzreg.2006.01.004","article-title":"Roles of the RAF\/MEK\/ERK and PI3K\/PTEN\/AKT pathways in malignant transformation and drug resistance","volume":"46","author":"McCubrey","year":"2006","journal-title":"Adv Enzyme Regul"},{"key":"key20180108101913_b19-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1124\/mol.106.023333","article-title":"Differential roles of phosphoinositide-dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to Paclitaxel, Doxorubicin, and gemcitabine","volume":"70","author":"Liang","year":"2006","journal-title":"Mol Pharmacol"},{"key":"key20180108101913_b20-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.4161\/cc.9.9.11544","article-title":"Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy","volume":"9","author":"Abrams","year":"2010","journal-title":"Cell Cycle"},{"key":"key20180108101913_b21-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/ol.2012.822","article-title":"The expression and clinical significance of PI3K, pAkt and VEGF in colon cancer","volume":"4","author":"Zhang","year":"2012","journal-title":"Oncol Lett"},{"key":"key20180108101913_b22-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000320761","article-title":"Clinical significance of genetic variations in the PI3K\/PTEN\/AKT\/mTOR pathway in Korean patients with colorectal cancer","volume":"79","author":"Kim","year":"2010","journal-title":"Oncology"},{"key":"key20180108101913_b23-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10147-012-0378-8","article-title":"Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1\u03b1) expression in gastric cancer","volume":"18","author":"Isobe","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"key20180108101913_b24-ol-07-05-1401","first-page":"1087","article-title":"Inhibition of phosphatidylinositol 3\u2032-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models","volume":"62","author":"Hu","year":"2002","journal-title":"Cancer Res"},{"key":"key20180108101913_b25-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2011.02.042","article-title":"Dual blockade of phosphatidylinositol 3\u2032-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer","volume":"306","author":"Xu","year":"2011","journal-title":"Cancer Lett"},{"key":"key20180108101913_b26-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1196\/annals.1397.012","article-title":"Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells","volume":"1095","author":"Kim","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"key20180108101913_b27-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/j.1349-7006.2007.00537.x","article-title":"Hypoxia inducible factor-1 influences sensitivity to paclitaxel of human lung cancer cell lines under normoxic conditions","volume":"98","author":"Zeng","year":"2007","journal-title":"Cancer Sci"},{"key":"key20180108101913_b28-ol-07-05-1401","first-page":"445","article-title":"Effect of PI3K\/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells","volume":"32","author":"Fekete","year":"2012","journal-title":"Anticancer Res"},{"key":"key20180108101913_b29-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2009.03.004","article-title":"PI3K\/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines","volume":"282","author":"Shafee","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180108101913_b30-ol-07-05-1401","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"},{"key":"key20180108101913_b31-ol-07-05-1401","first-page":"461","article-title":"Activation of PI3 kinase\/Akt\/HIF-1\u03b1 pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma","volume":"40","author":"Jiao","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180108101913_b32-ol-07-05-1401","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/1471-2407-11-338","article-title":"A novel inhibitor of hypoxia-inducible factor-1\u03b1 P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells","volume":"11","author":"Manohar","year":"2011","journal-title":"BMC Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2014.1963\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T08:07:29Z","timestamp":1515398849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2014.1963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,11]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,3,11]]},"published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.3892\/ol.2014.1963"],"URL":"https:\/\/doi.org\/10.3892\/ol.2014.1963","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,11]]}}}